LataMed AI's 5-for-1 Forward Stock Split Expected Next Week, New CUSIP Assigned
LMED has more than doubled off its 52-week low of $0.265 on elevated volume (2.6× avg).
Summary
LataMed AI Corp. provided an update on its previously announced 5-for-1 forward stock split, stating that FINRA has received all necessary documentation. Management anticipates the split will become effective within approximately the next week, accompanied by a new CUSIP number. This corporate action, which follows the company's May 14th announcement of its intent to split, will significantly increase the number of outstanding shares and reduce the per-share price, impacting trading mechanics for an OTC stock currently trading at $3.85. Shareholders should prepare for automatic adjustments to their holdings. The company's official effective date from FINRA is still pending.
At the time of this announcement, LMED was trading at $3.85 on OTC in the Technology sector, with a market capitalization of approximately $217.2M. The 52-week trading range was $0.27 to $675.01. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: EQS.